Environmental Engineering Reference
In-Depth Information
Hermsdorf, D., Jauer, S., and Signorell, R. 2007. Formation and stabilization of ibuprofen nanoparticles by
pulsed rapid expansion of supercritical solutions.
Molecular Physics
, 105(8):951-959.
Hickey, A.J. (Ed.) 2004.
Pharmaceutical Inhalation Aerosol Technology
, Informa Health Care, London, U.K.
Hinds, W.C. 1999.
Aerosol Technology. Properties, Behavior, and Measurement of Airborne Particles
, 2nd
edn., John Wiley & Sons, Inc., New York.
Kirsh, A.A., Stechkina, I.B., and Fuchs, N.A. 1975. Eficiency of aerosol ilters made of ultraine polydisperse
ibres.
Journal of Aerosol Science
, 5:119-124.
Koster, R., Anderson, M., and Deber, E.I. 1959. Acetic acid for analgesic screening.
Federation Proceedings
,
18:412-414.
Laube, B.L. 2005. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination.
Respiratory Care
, 50:1161-1176.
Lee, T., Chen, Y.H., and Wang, Y.W. 2008. Effects of homochiral molecules of (S)-(+)-ibuprofen and (S)-(−)-
sodium ibuprofen dihydrate on the crystallization kinetics of racemic (R,S)-(±)-sodium ibuprofen dihy-
drate.
Crystal Growth and Design
, 8(2):415-426.
Meade, E.A., Smith, W.L., and DeWittm D.L. 1993. Differential inhibition of prostaglandin endoperoxide
synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal antiinlammatory drugs.
Journal
of Biological Chemistry
, 268(9):6610-6614.
Mutschler, E. and Derendorf, H. 1995.
Drug Actions. Basic Principles and Therapeutic Aspects
, Medpharm,
Stuttgart, Germany, pp. 170-171.
Nada, A.H., Al-Saidan, S.M., and Mueller, B.W. 2005. Crystal modiication for improving physical and chemi-
cal properties of ibuprofen.
Pharmaceutical Technology
, 29:90-101.
Oberdörster, G., Oberdörster, E., and Oberdörster, J. 2005. Nanotoxicology: An emerging discipline evolving
from studies of ultraine particles.
Environmental Health Perspectives
, 113:823-839.
Onischuk, A.A., Tolstikova, T.G., Sorokina, I.V., Zhukova, N.A., Baklanov, A.M., Karasev, V.V., Dultseva,
G.G., Boldyrev, V.V., and Fomin, V.M. 2008. Anti-inlammatory effect from indomethacin nanoparticles
inhaled by male mice.
Journal of Aerosol Medicine and Pulmonary Drug Delivery
, 21(3):231-244.
Rabinowitz, J.D. and Zaffaroni, A.C. 2004. Delivery of nonsteroidal antiinlammatory drugs through an inhala-
tion route. United States Patent 7087217.
Rubin, B.K. and Fink, J.B. 2005. Optimizing aerosol delivery by pressurized metered-dose inhalers.
Respiratory
Care
, 50:1191-1200.
Schaper, M. and Brost, M.A. 1991. Respiratory effects of trimellitic anhydride aerosols in mice.
Archives of
Toxicology
, 65:671-677.
Skyler, J.S. 2007. Pulmonary insulin delivery—State of the art 2007.
Diabetes Technology and Therapeutics
,
9:S1-S3.
Stahly, G.P., Mckenzie, A.T., Andres, M.C., Russell, C.A., Byrn, S.R., and Johnson, P. 1997. Determination
of the optical purity of ibuprofen using x-ray powder diffraction.
Journal of Pharmaceutical Sciences
,
86(8), 970-971.
Vijayaraghavan, R. 1997. Modiications of breathing pattern induced by inhaled sulphur mustard in mice.
Archives of Toxicology
, 71:157-164.
Wong, B.A. 2007. Inhalation exposure systems: Design, methods and operation.
Toxicologic Pathology
,
35:3-14.
11.2
PART II. STUDY OF THE TOXIC-PHARMACOLOGICAL
PROPERTIES OF NANOSTRUCTURED DRUG FORMS
T.G. Tolstikova, M. Khvostov, A. Bryzgalov, and G.A. Tolstikov
11.2.1 i
ntroduction
Modern medicine operates a broad spectrum of drugs to treat patients with different diseases.
However, a wider application of most of the drugs is impeded by their low bioavailability because
of insuficient water-solubility and different toxic effects.
Thereby, the development of water-soluble, low-toxic, safe and high-effective drugs is very sig-
niicant for modern pharmacology and medicine.
Search WWH ::
Custom Search